Compagnie Chargeurs Invest Enters Exclusive Negotiations for Novacel Sale

Compagnie Chargeurs Invest has announced exclusive negotiations for the potential sale of a controlling stake in its subsidiary, Novacel, to KPS Capital Partners. The agreement reflects Chargeurs' plan to capitalize on Novacel's growth while retaining a 25% stake. This move aligns with Chargeurs' long-term strategy to boost equity capital and potentially issue a special dividend.

The agreement, currently non-binding, is expected to conclude in the first half of 2026, pending further due diligence and regulatory approval. The transaction, entirely in cash, follows a competitive process considering several investment expressions of interest.

Chargeurs aims to identify a strong partner to amplify Novacel's global success. If finalized, the proceeds will also reduce Chargeurs' debt and support new business investments. Maintaining operational and financial flexibility remains a priority in this strategic shift.